Aurobindo gets USFDA nod to market generic Osteoporosis drug

The company has received final approval from US Food & Drug Administration (USFDA) to manufacture and market Risedronate Sodium tablets, Aurobindo Pharma said in a statement.PTI | December 01, 2015, 17:18 IST